tradingkey.logo

Meihua International Medical Technologies Co Ltd

MHUA
7.610USD
0.000
收盤 12/24, 13:00美東報價延遲15分鐘
2.41M總市值
0.25本益比TTM

Meihua International Medical Technologies Co Ltd

7.610
0.000

關於 Meihua International Medical Technologies Co Ltd 公司

Meihua International Medical Technologies Co Ltd is a holding company mainly engaged in the research, development, manufacturing and sales of Class I, Class II and Class III disposable medical devices. The Company's products include self-manufactured and out-sourced products. Class I disposable medical devices include disposable medical X-ray films, medical dry films, dry laser imagers, gauze bandages, examination gloves, pharmaceutical packaging materials and containers, low-density polyethylene (LDPE) bottles for eye drops, high-density polyethylene (HDPE) bottles for tablets, and others. Class II disposable medical devices include disposable full anesthesia kits, medical brush, woman's examination kits, urethral catheterization kits, gynecological examination kits, endotracheal intubation, medical masks, anal bags, and suction connecting tube, and others. Class III disposable medical devices include disposable infusion pumps, anesthesia puncture kits, electronic pumps, and others.

Meihua International Medical Technologies Co Ltd簡介

公司代碼MHUA
公司名稱Meihua International Medical Technologies Co Ltd
上市日期Feb 16, 2022
CEOWang (Yulin)
員工數量619
證券類型Ordinary Share
年結日Feb 16
公司地址88 Tongda Road, Touqiao Town, Guangling District
城市YANGZHOU
上市交易所NASDAQ OMX - NASDAQ BASIC
國家China
郵編225000
電話8651489800199
網址https://meihuamed.com/
公司代碼MHUA
上市日期Feb 16, 2022
CEOWang (Yulin)

Meihua International Medical Technologies Co Ltd公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Yongjun Liu
Mr. Yongjun Liu
Chairman of the Board
Chairman of the Board
159.35K
--
Mr. Yulin Wang
Mr. Yulin Wang
Chief Executive Officer, Interim Chief Financial Officer, Director
Chief Executive Officer, Interim Chief Financial Officer, Director
--
--
Mr. Xiaoming E
Mr. Xiaoming E
Independent Director
Independent Director
--
--
Mr. Xu Han
Mr. Xu Han
Independent Director
Independent Director
--
--
Mr. Wenzhang Jia
Mr. Wenzhang Jia
Independent Director
Independent Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Yongjun Liu
Mr. Yongjun Liu
Chairman of the Board
Chairman of the Board
159.35K
--
Mr. Yulin Wang
Mr. Yulin Wang
Chief Executive Officer, Interim Chief Financial Officer, Director
Chief Executive Officer, Interim Chief Financial Officer, Director
--
--
Mr. Xiaoming E
Mr. Xiaoming E
Independent Director
Independent Director
--
--
Mr. Xu Han
Mr. Xu Han
Independent Director
Independent Director
--
--
Mr. Wenzhang Jia
Mr. Wenzhang Jia
Independent Director
Independent Director
--
--

收入明細

單位: USD更新時間: 10月6日 週一
單位: USD更新時間: 10月6日 週一
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
業務USD
名稱
營收
佔比
Resales of Sourced Disposable Medical Devices from Third Party Manufacturers
49.30M
50.88%
Self-Manufactured Products
47.61M
49.12%
由於公司未披露,未能獲取相關數據
業務
地區
業務USD
名稱
營收
佔比
Resales of Sourced Disposable Medical Devices from Third Party Manufacturers
49.30M
50.88%
Self-Manufactured Products
47.61M
49.12%

股東統計

更新時間: 11月17日 週一
更新時間: 11月17日 週一
持股股東
股東類型
持股股東
持股股東
佔比
Liu (Yongjun)
22.83%
XTX Markets LLC
0.05%
Renaissance Technologies LLC
0.04%
Marex Group plc
0.04%
Citadel Advisors LLC
0.03%
其他
77.01%
持股股東
持股股東
佔比
Liu (Yongjun)
22.83%
XTX Markets LLC
0.05%
Renaissance Technologies LLC
0.04%
Marex Group plc
0.04%
Citadel Advisors LLC
0.03%
其他
77.01%
股東類型
持股股東
佔比
Individual Investor
28.50%
Hedge Fund
0.10%
Venture Capital
0.06%
Investment Advisor
0.04%
Investment Advisor/Hedge Fund
0.02%
其他
71.28%

機構持股

更新時間: 10月1日 週三
更新時間: 10月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
15
164.61K
0.52%
-2.53M
2025Q2
14
16.27M
51.01%
-2.20M
2025Q1
18
16.27M
51.01%
-2.22M
2024Q4
19
16.19M
50.75%
-2.28M
2024Q3
18
18.39M
58.65%
+1.61M
2024Q2
17
16.65M
52.69%
+166.88K
2024Q1
18
16.39M
51.82%
+107.48K
2023Q4
16
16.23M
51.17%
+182.79K
2023Q3
13
15.99M
66.79%
-24.95K
2023Q2
13
15.96M
66.67%
-82.11K
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
Liu (Yongjun)
15.94M
49.95%
--
--
Dec 31, 2024
XTX Markets LLC
--
0%
-19.00K
-100.00%
Jun 30, 2025
Renaissance Technologies LLC
24.10K
0.08%
+11.70K
+94.35%
Jun 30, 2025
Marex Group plc
16.21K
0.05%
+16.21K
--
Jun 30, 2025
Citadel Advisors LLC
--
0%
-150.52K
-100.00%
Jun 30, 2025
Geode Capital Management, L.L.C.
14.39K
0.05%
--
--
Jun 30, 2025
UBS Financial Services, Inc.
93.66K
0.29%
+7.38K
+8.56%
Jun 30, 2025
Two Sigma Investments, LP
16.25K
0.05%
-11.58K
-41.61%
Jun 30, 2025
Virtu Americas LLC
--
0%
-41.36K
-100.00%
Mar 31, 2025
HRT Financial LP
--
0%
-33.44K
-100.00%
Mar 31, 2025
查看更多

持股ETF

機構名稱
佔比
暫無數據

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據

常見問題

Meihua International Medical Technologies Co Ltd的前五大股東是誰?

Meihua International Medical Technologies Co Ltd的前五大股東如下:
Liu (Yongjun)
持有股份:15.94M
佔總股份比例:49.95%。
XTX Markets LLC
持有股份:0.00
佔總股份比例:0.00%。
Renaissance Technologies LLC
持有股份:24.10K
佔總股份比例:0.08%。
Marex Group plc
持有股份:16.21K
佔總股份比例:0.05%。
Citadel Advisors LLC
持有股份:0.00
佔總股份比例:0.00%。

Meihua International Medical Technologies Co Ltd的前三大股東類型是什麼?

Meihua International Medical Technologies Co Ltd 的前三大股東類型分別是:
Liu (Yongjun)
XTX Markets LLC
Renaissance Technologies LLC

有多少機構持有Meihua International Medical Technologies Co Ltd(MHUA)的股份?

截至2025Q3,共有15家機構持有Meihua International Medical Technologies Co Ltd的股份,合計持有的股份價值約為164.61K,占公司總股份的0.52% 。與2025Q2相比,機構持股有所增加,增幅為-50.49%。

哪個業務部門對Meihua International Medical Technologies Co Ltd的收入貢獻最大?

在FY2024,Resales of Sourced Disposable Medical Devices from Third Party Manufacturers業務部門對Meihua International Medical Technologies Co Ltd的收入貢獻最大,創收49.30M,占總收入的50.88% 。
KeyAI